SCHEMBL7975682

SCHEMBL7975682

O=Cc1ccc2c(c1)ncn2-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 14/20 0.67
ALDH1A1 P00352 1/20 0.57
HTT P42858 1/20 0.57
SRC P12931 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2642021 0.89 FGFR1 (0.65) FGFR1ALDH1A1HTT
SCHEMBL17940759 0.88 FGFR1 (0.67) FGFR1ALDH1A1HTTSRC
SCHEMBL23675204 0.85 FGFR1 (0.65) FGFR1ALDH1A1
SCHEMBL30033882 0.85 FGFR1 (0.65) FGFR1ALDH1A1
SCHEMBL2649006 0.84 FGFR1 (0.67) FGFR1ALDH1A1
SCHEMBL28722636 0.84 FGFR1 (0.63) FGFR1ALDH1A1
SCHEMBL2654246 0.83 FGFR1 (0.61) FGFR1ALDH1A1
SCHEMBL29512158 0.82 FGFR1 (0.72) FGFR1ALDH1A1HTT
SCHEMBL2568999 0.82 FGFR1 (0.72) FGFR1ALDH1A1HTT
SCHEMBL25881861 0.81 FGFR1 (0.52) FGFR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed
US-5990146-A TREATING PROTEIN TYROSINE KINASE MEDIATED CANCER; ANTICARCINOGENIC AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS; ANTIPROLIFERATIVE AGENTS WARNER-LAMBERT COMPANY (US) 1999-11-23 US disclosed